查看購物車
  • Simplified Chinese
  • English
  • Japanese
  • Korean
全球 COVID-19 診斷市場——行業分析、規模、份額、增長、趨勢、預測，2022-2031 年
市場調查報告書
商品編碼
1229587

全球 COVID-19 診斷市場——行業分析、規模、份額、增長、趨勢、預測，2022-2031 年

COVID-19 Diagnostics Market (Product: Instruments and Reagents & Kits; Test Type: Molecular Tests, Antigen Tests, and Antibody Tests) - Global Industry Analysis, Size, Share, Growth, Trends, and Forecast, 2022-2031
出版日期: | 出版商: Transparency Market Research | 英文 226 Pages | 商品交期: 2-10個工作天內

價格

本報告介紹了 2017 年至 2031 年全球 COVID-19 診斷市場的收入，基準年為 2022 年，預測年為 2031 年。它還介紹了 2022 年至 2031 年全球 COVID-19 診斷市場的複合年增長率 (CAGR %)。

本報告是廣泛研究的結果。在初步研究中，分析師對主要思想領袖、行業領袖和輿論製造者進行訪談，他們提供了大量的研究工作。在二次調研中，我們參考了各大公司的產品資料、年報、新聞稿、相關文件等，瞭解COVID-19診斷市場。

該報告深入探討了全球 COVID-19 診斷市場的競爭格局。已經確定了在全球 COVID-19 診斷市場上運營的主要參與者，並根據各種屬性對每家公司進行了介紹。公司概況、財務狀況、近期發展和 SWOT 是本報告中描述的全球 COVID-19 診斷市場參與者的屬性。

目錄

第一章 前言

  • 市場定義和範圍
  • 市場細分
  • 主要研究目的
  • 調查亮點

第二章前提條件和研究方法

第 3 章執行摘要：全球 COVID-19 診斷市場

第四章市場概況

  • 介紹
    • 段定義
    • 行業的演變與發展
  • 概述
  • 市場動態
    • 促進者
    • 抑製劑
    • 機會
  • 2020-2031 年 COVID-19 診斷全球市場分析與預測

第 5 章關鍵見解

  • 技術進步
  • COVID-19抗原診斷測試管道
  • 關於 FDA 批准的家庭診斷 "COVID-19" 的思考
  • 各國對 COVID-19 診斷的監管批准

第 6 章 COVID-19 診斷的全球市場分析和預測：按產品分類

  • 介紹和定義
  • 重大發現/發展
  • 市場價值預測：按產品分類，2020-2031 年
    • 機器
    • 試劑/試劑盒
  • 市場吸引力分析：按產品

第 7 章 COVID-19 診斷的全球市場分析和預測：按測試類型

  • 介紹和定義
  • 重大發現/發展
  • 市場價值預測：按測試類型，2020-2031 年
    • 分子生物學測試
    • 抗原檢測
    • 抗體（血清學）測試
  • 市場吸引力分析：按測試類型

第 8 章 COVID-19 診斷的全球市場分析和預測：最終用戶

  • 介紹和定義
  • 重大發現/發展
  • 市場價值預測：按最終用戶分類，2020-2031 年
    • 醫院/診所
    • 在家測試
    • 其他
  • 市場吸引力分析：按最終用戶

第 9 章 COVID-19 診斷的全球市場分析和預測：按地區

  • 主要發現
  • 市場價值預測：按地區劃分，2020-2031 年
    • 北美
    • 歐洲
    • 亞太地區
    • 拉丁美洲
    • 中東/非洲
  • 市場吸引力分析：按地區

第 10 章北美 COVID-19 診斷市場分析與預測

  • 介紹
    • 主要發現
  • 市場價值預測：按產品分類，2020-2031 年
    • 機器
    • 試劑/試劑盒
  • 市場價值預測：按測試類型，2020-2031 年
    • 分子生物學測試
    • 抗原檢測
    • 抗體（血清學）測試
  • 市場價值預測：按最終用戶分類，2020-2031 年
    • 醫院/診所
    • 在家測試
    • 其他
  • 2020-2031 年各國市場價值預測
    • 美國
    • 加拿大
  • 市場吸引力分析
    • 按產品
    • 按測試類型
    • 按最終用戶
    • 按國家

第 11 章歐洲 COVID-19 診斷市場分析與預測

  • 介紹
    • 主要發現
  • 市場價值預測：按產品分類，2020-2031 年
    • 機器
    • 試劑/試劑盒
  • 市場價值預測：按測試類型，2020-2031 年
    • 分子生物學測試
    • 抗原檢測
    • 抗體（血清學）測試
  • 市場價值預測：按最終用戶分類，2020-2031 年
    • 醫院/診所
    • 在家測試
    • 其他
  • 市場價值預測：按國家/地區分類，2020-2031 年
    • 德國
    • 英國
    • 法國
    • 意大利
    • 西班牙
    • 歐洲其他地區
  • 市場吸引力分析
    • 按產品
    • 按測試類型
    • 按最終用戶
    • 按國家/地區

第 12 章亞太 COVID-19 診斷市場分析與預測

  • 介紹
    • 主要發現
  • 市場價值預測：按產品分類，2020-2031 年
    • 機器
    • 試劑/試劑盒
  • 市場價值預測：按測試類型，2020-2031 年
    • 分子生物學測試
    • 抗原檢測
    • 抗體（血清）檢測
  • 市場價值預測：按最終用戶分類，2020-2031 年
    • 醫院/診所
    • 在家測試
    • 其他
  • 市場價值預測：按國家/地區分類，2020-2031 年
    • 中國
    • 日本
    • 印度
    • 澳大利亞/新西蘭
    • 亞太其他地區
  • 市場吸引力分析
    • 按產品
    • 按測試類型
    • 按最終用戶
    • 按國家/地區

第 13 章拉丁美洲 COVID-19 診斷市場分析與預測

  • 介紹
    • 主要發現
  • 市場價值預測：按產品分類，2020-2031 年
    • 機器
    • 試劑/試劑盒
  • 市場價值預測：按測試類型，2020-2031 年
    • 分子生物學測試
    • 抗原檢測
    • 抗體（血清學）測試
  • 市場價值預測：按最終用戶分類，2020-2031 年
    • 醫院/診所
    • 在家測試
    • 其他
  • 市場價值預測：按國家/地區分類，2020-2031 年
    • 巴西
    • 墨西哥
    • 其他拉丁美洲地區
  • 市場吸引力分析
    • 按產品
    • 按測試類型
    • 按最終用戶
    • 按國家/地區

第 14 章中東和非洲 COVID-19 診斷市場分析與預測

  • 介紹
    • 主要發現
  • 市場價值預測：按產品分類，2020-2031 年
    • 機器
    • 試劑/試劑盒
  • 市場價值預測：按測試類型，2020-2031 年
    • 分子生物學測試
    • 抗原檢測
    • 抗體（血清學）測試
  • 市場價值預測：按最終用戶分類，2020-2031 年
    • 醫院/診所
    • 在家測試
    • 其他
  • 市場價值預測：按國家/地區分類，2020-2031 年
    • 海灣合作委員會國家
    • 南非
    • 中東和非洲其他地區
  • 市場吸引力分析
    • 按產品
    • 按測試類型
    • 按最終用戶
    • 按國家/地區

第十五章競爭格局

  • 市場參與者 - 競爭矩陣（按公司級別、公司規模）
  • 市場份額分析：按公司分類，2021 年
  • 公司簡介
    • Abbott Laboratories
    • Becton, Dickinson and Company（BD）
    • Bio-Rad Laboratories, Inc.
    • Danaher Corporation（Cepheid）
    • F. Hoffmann-La Roche Ltd.（Roche Diagnostics）
    • Hologic, Inc.
    • Laboratory Corporation of America Holdings
    • PerkinElmer, Inc.
    • Quest Diagnostics
    • Thermo Fisher Scientific, Inc.
Product Code: TMRGL80305

The report provides revenue of the global COVID-19 diagnostics market for the period 2017-2031, considering 2022 as the base year and 2031 as the forecast year. The report also provides the compound annual growth rate (CAGR %) of the global COVID-19 diagnostics market from 2022 to 2031.

The report has been prepared after an extensive research. Primary research involved bulk of the research efforts, wherein analysts carried out interviews with key opinion leaders, industry leaders, and opinion makers. Secondary research involved referring to key players' product literature, annual reports, press releases, and relevant documents to understand the COVID-19 diagnostics market.

The report delves into the competitive landscape of the global COVID-19 diagnostics market. Key players operating in the global COVID-19 diagnostics market have been identified and each one of these has been profiled, in terms of various attributes. Company overview, financial standings, recent developments, and SWOT are attributes of players in the global COVID-19 diagnostics market profiled in this report.

Table of Contents

1. Preface

  • 1.1. Market Definition and Scope
  • 1.2. Market Segmentation
  • 1.3. Key Research Objectives
  • 1.4. Research Highlights

2. Assumptions and Research Methodology

3. Executive Summary: Global COVID-19 Diagnostics Market

4. Market Overview

  • 4.1. Introduction
    • 4.1.1. Segment Definition
    • 4.1.2. Industry Evolution / Developments
  • 4.2. Overview
  • 4.3. Market Dynamics
    • 4.3.1. Drivers
    • 4.3.2. Restraints
    • 4.3.3. Opportunities
  • 4.4. Global COVID-19 Diagnostics Market Analysis and Forecast, 2020-2031

5. Key Insights

  • 5.1. Technological Advancements
  • 5.2. COVID-19 Antigen Diagnostic Test Pipeline
  • 5.3. Insights on FDA Approved COVID-19 Home Diagnostic Test
  • 5.4. Regulatory Authorizations by Country for COVID-19 Diagnostic Tests

6. Global COVID-19 Diagnostics Market Analysis and Forecast, by Product

  • 6.1. Introduction & Definition
  • 6.2. Key Findings/Developments
  • 6.3. Market Value Forecast, by Product, 2020-2031
    • 6.3.1. Instruments
    • 6.3.2. Reagents & Kits
  • 6.4. Market Attractiveness Analysis, by Product

7. Global COVID-19 Diagnostics Market Analysis and Forecast, by Test Type

  • 7.1. Introduction & Definition
  • 7.2. Key Findings/Developments
  • 7.3. Market Value Forecast, by Test Type, 2020-2031
    • 7.3.1. Molecular Tests
    • 7.3.2. Antigen Test
    • 7.3.3. Antibody (serology) Tests
  • 7.4. Market Attractiveness Analysis, by Test Type

8. Global COVID-19 Diagnostics Market Analysis and Forecast, by End-user

  • 8.1. Introduction & Definition
  • 8.2. Key Findings/Developments
  • 8.3. Market Value Forecast, by End-user, 2020-2031
    • 8.3.1. Hospitals & Clinics
    • 8.3.2. At-home Testing
    • 8.3.3. Others
  • 8.4. Market Attractiveness Analysis, by End-user

9. Global COVID-19 Diagnostics Market Analysis and Forecast, by Region

  • 9.1. Key Findings
  • 9.2. Market Value Forecast, by Region, 2020-2031
    • 9.2.1. North America
    • 9.2.2. Europe
    • 9.2.3. Asia Pacific
    • 9.2.4. Latin America
    • 9.2.5. Middle East & Africa
  • 9.3. Market Attractiveness Analysis, by Region

10. North America COVID-19 Diagnostics Market Analysis and Forecast

  • 10.1. Introduction
    • 10.1.1. Key Findings
  • 10.2. Market Value Forecast, by Product, 2020-2031
    • 10.2.1. Instruments
    • 10.2.2. Reagents & Kits
  • 10.3. Market Value Forecast, by Test Type, 2020-2031
    • 10.3.1. Molecular Tests
    • 10.3.2. Antigen Test
    • 10.3.3. Antibody (serology) Tests
  • 10.4. Market Value Forecast, by End-user, 2020-2031
    • 10.4.1. Hospitals & Clinics
    • 10.4.2. At-home Testing
    • 10.4.3. Others
  • 10.5. Market Value Forecast, by Country, 2020-2031
    • 10.5.1. U.S.
    • 10.5.2. Canada
  • 10.6. Market Attractiveness Analysis
    • 10.6.1. By Product
    • 10.6.2. By Test Type
    • 10.6.3. By End-user
    • 10.6.4. By Country

11. Europe COVID-19 Diagnostics Market Analysis and Forecast

  • 11.1. Introduction
    • 11.1.1. Key Findings
  • 11.2. Market Value Forecast, by Product, 2020-2031
    • 11.2.1. Instruments
    • 11.2.2. Reagents & Kits
  • 11.3. Market Value Forecast, by Test Type, 2020-2031
    • 11.3.1. Molecular Tests
    • 11.3.2. Antigen Test
    • 11.3.3. Antibody (serology) Tests
  • 11.4. Market Value Forecast, by End-user, 2020-2031
    • 11.4.1. Hospitals & Clinics
    • 11.4.2. At-home Testing
    • 11.4.3. Others
  • 11.5. Market Value Forecast, by Country/Sub-region, 2020-2031
    • 11.5.1. Germany
    • 11.5.2. U.K.
    • 11.5.3. France
    • 11.5.4. Italy
    • 11.5.5. Spain
    • 11.5.6. Rest of Europe
  • 11.6. Market Attractiveness Analysis
    • 11.6.1. By Product
    • 11.6.2. By Test Type
    • 11.6.3. By End-user
    • 11.6.4. By Country/Sub-region

12. Asia Pacific COVID-19 Diagnostics Market Analysis and Forecast

  • 12.1. Introduction
    • 12.1.1. Key Findings
  • 12.2. Market Value Forecast, by Product, 2020-2031
    • 12.2.1. Instruments
    • 12.2.2. Reagents & Kits
  • 12.3. Market Value Forecast, by Test Type, 2020-2031
    • 12.3.1. Molecular Tests
    • 12.3.2. Antigen Test
    • 12.3.3. Antibody (Serology) Tests
  • 12.4. Market Value Forecast, by End-user, 2020-2031
    • 12.4.1. Hospitals & Clinics
    • 12.4.2. At-home Testing
    • 12.4.3. Others
  • 12.5. Market Value Forecast, by Country/Sub-region, 2020-2031
    • 12.5.1. China
    • 12.5.2. Japan
    • 12.5.3. India
    • 12.5.4. Australia & New Zealand
    • 12.5.5. Rest of Asia Pacific
  • 12.6. Market Attractiveness Analysis
    • 12.6.1. By Product
    • 12.6.2. By Test Type
    • 12.6.3. By End-user
    • 12.6.4. By Country/Sub-region

13. Latin America COVID-19 Diagnostics Market Analysis and Forecast

  • 13.1. Introduction
    • 13.1.1. Key Findings
  • 13.2. Market Value Forecast, by Product, 2020-2031
    • 13.2.1. Instruments
    • 13.2.2. Reagents & Kits
  • 13.3. Market Value Forecast, by Test Type, 2020-2031
    • 13.3.1. Molecular Tests
    • 13.3.2. Antigen Test
    • 13.3.3. Antibody (serology) Tests
  • 13.4. Market Value Forecast, by End-user, 2020-2031
    • 13.4.1. Hospitals & Clinics
    • 13.4.2. At-home Testing
    • 13.4.3. Others
  • 13.5. Market Value Forecast, by Country/Sub-region, 2020-2031
    • 13.5.1. Brazil
    • 13.5.2. Mexico
    • 13.5.3. Rest of Latin America
  • 13.6. Market Attractiveness Analysis
    • 13.6.1. By Product
    • 13.6.2. By Test Type
    • 13.6.3. By End-user
    • 13.6.4. By Country/Sub-region

14. Middle East & Africa COVID-19 Diagnostics Market Analysis and Forecast

  • 14.1. Introduction
    • 14.1.1. Key Findings
  • 14.2. Market Value Forecast, by Product, 2020-2031
    • 14.2.1. Instruments
    • 14.2.2. Reagents & Kits
  • 14.3. Market Value Forecast, by Test Type, 2020-2031
    • 14.3.1. Molecular Tests
    • 14.3.2. Antigen Test
    • 14.3.3. Antibody (serology) Tests
  • 14.4. Market Value Forecast, by End-user, 2020-2031
    • 14.4.1. Hospitals & Clinics
    • 14.4.2. At-home Testing
    • 14.4.3. Others
  • 14.5. Market Value Forecast, by Country/Sub-region, 2020-2031
    • 14.5.1. GCC Countries
    • 14.5.2. South Africa
    • 14.5.3. Rest of MEA
  • 14.6. Market Attractiveness Analysis
    • 14.6.1. By Product
    • 14.6.2. By Test Type
    • 14.6.3. By End-user
    • 14.6.4. By Country/Sub-region

15. Competition Landscape

  • 15.1. Market Player - Competitive Matrix (by tier and size of companies)
  • 15.2. Market Share Analysis, by Company, 2021
  • 15.3. Company Profiles
    • 15.3.1. Abbott Laboratories
      • 15.3.1.1. Company Overview
      • 15.3.1.2. Product Portfolio
      • 15.3.1.3. SWOT Analysis
      • 15.3.1.4. Financial Overview
      • 15.3.1.5. Strategic Overview
    • 15.3.2. Becton, Dickinson and Company (BD)
      • 15.3.2.1. Company Overview
      • 15.3.2.2. Product Portfolio
      • 15.3.2.3. SWOT Analysis
      • 15.3.2.4. Financial Overview
      • 15.3.2.5. Strategic Overview
    • 15.3.3. Bio-Rad Laboratories, Inc.
      • 15.3.3.1. Company Overview
      • 15.3.3.2. Product Portfolio
      • 15.3.3.3. SWOT Analysis
      • 15.3.3.4. Financial Overview
      • 15.3.3.5. Strategic Overview
    • 15.3.4. Danaher Corporation (Cepheid)
      • 15.3.4.1. Company Overview
      • 15.3.4.2. Product Portfolio
      • 15.3.4.3. SWOT Analysis
      • 15.3.4.4. Financial Overview
      • 15.3.4.5. Strategic Overview
    • 15.3.5. F. Hoffmann-La Roche Ltd. (Roche Diagnostics)
      • 15.3.5.1. Company Overview
      • 15.3.5.2. Product Portfolio
      • 15.3.5.3. SWOT Analysis
      • 15.3.5.4. Financial Overview
      • 15.3.5.5. Strategic Overview
    • 15.3.6. Hologic, Inc.
      • 15.3.6.1. Company Overview
      • 15.3.6.2. Product Portfolio
      • 15.3.6.3. SWOT Analysis
      • 15.3.6.4. Financial Overview
      • 15.3.6.5. Strategic Overview
    • 15.3.7. Laboratory Corporation of America Holdings
      • 15.3.7.1. Company Overview
      • 15.3.7.2. Product Portfolio
      • 15.3.7.3. SWOT Analysis
      • 15.3.7.4. Financial Overview
      • 15.3.7.5. Strategic Overview
    • 15.3.8. PerkinElmer, Inc.
      • 15.3.8.1. Company Overview
      • 15.3.8.2. Product Portfolio
      • 15.3.8.3. SWOT Analysis
      • 15.3.8.4. Financial Overview
      • 15.3.8.5. Strategic Overview
    • 15.3.9. Quest Diagnostics
      • 15.3.9.1. Company Overview
      • 15.3.9.2. Product Portfolio
      • 15.3.9.3. SWOT Analysis
      • 15.3.9.4. Financial Overview
      • 15.3.9.5. Strategic Overview
    • 15.3.10. Thermo Fisher Scientific, Inc.
      • 15.3.10.1. Company Overview
      • 15.3.10.2. Product Portfolio
      • 15.3.10.3. SWOT Analysis
      • 15.3.10.4. Financial Overview
      • 15.3.10.5. Strategic Overview

List of Tables

  • Table 01: Global COVID-19 Diagnostics Market Size (US$ Mn) Forecast, by Product, 2020-2031
  • Table 02: Global COVID-19 Diagnostics Market Size (US$ Mn) Forecast, by Test Type, 2020-2031
  • Table 03: Global COVID-19 Diagnostics Market Size (US$ Mn) Forecast, by End-user, 2020-2031
  • Table 04: Global COVID-19 Diagnostics Market Size (US$ Mn) Forecast, by Region, 2020-2031
  • Table 05: North America COVID-19 Diagnostics Market Size (US$ Mn) Forecast, by Country, 2020-2031
  • Table 06: North America COVID-19 Diagnostics Market Size (US$ Mn) Forecast, by Product, 2020-2031
  • Table 07: North America COVID-19 Diagnostics Market Size (US$ Mn) Forecast, by Test Type, 2020-2031
  • Table 08: North America COVID-19 Diagnostics Market Size (US$ Mn) Forecast, by End-user, 2020-2031
  • Table 09: Europe COVID-19 Diagnostics Market Size (US$ Mn) Forecast, by Country/Sub-region, 2020-2031
  • Table 10: Europe COVID-19 Diagnostics Market Size (US$ Mn) Forecast, by Product, 2020-2031
  • Table 11: Europe COVID-19 Diagnostics Market Size (US$ Mn) Forecast, by Test Type, 2020-2031
  • Table 12: Europe COVID-19 Diagnostics Market Size (US$ Mn) Forecast, by End-user, 2020-2031
  • Table 13: Asia Pacific COVID-19 Diagnostics Market Size (US$ Mn) Forecast, by Country/Sub-region, 2020-2031
  • Table 14: Asia Pacific COVID-19 Diagnostics Market Size (US$ Mn) Forecast, by Product, 2020-2031
  • Table 15: Asia Pacific COVID-19 Diagnostics Market Size (US$ Mn) Forecast, by Test Type, 2020-2031
  • Table 16: Asia Pacific COVID-19 Diagnostics Market Size (US$ Mn) Forecast, by End-user, 2020-2031
  • Table 17: Latin America COVID-19 Diagnostics Market Size (US$ Mn) Forecast, by Country/Sub-region, 2020-2031
  • Table 18: Latin America COVID-19 Diagnostics Market Size (US$ Mn) Forecast, by Product, 2020-2031
  • Table 19: Latin America COVID-19 Diagnostics Market Size (US$ Mn) Forecast, by Test Type, 2020-2031
  • Table 20: Latin America COVID-19 Diagnostics Market Size (US$ Mn) Forecast, by End-user, 2020-2031
  • Table 21: Middle East & Africa COVID-19 Diagnostics Market Size (US$ Mn) Forecast, by Country/Sub-region, 2020-2031
  • Table 22: Middle East & Africa COVID-19 Diagnostics Market Size (US$ Mn) Forecast, by Product, 2020-2031
  • Table 23: Middle East & Africa COVID-19 Diagnostics Market Size (US$ Mn) Forecast, by Test Type, 2020-2031
  • Table 24: Middle East & Africa COVID-19 Diagnostics Market Size (US$ Mn) Forecast, by End-user, 2020-2031

List of Figures

  • Figure 01: Global COVID-19 Diagnostics Market Size (US$ Mn) and Distribution (%), by Region, 2021 and 2031
  • Figure 02: Global COVID-19 Diagnostics Market Revenue (US$ Mn), by Product, 2021
  • Figure 03: Global COVID-19 Diagnostics Market Value Share, by Product, 2021
  • Figure 04: Global COVID-19 Diagnostics Market Revenue (US$ Mn), by Test Type, 2021
  • Figure 05: Global COVID-19 Diagnostics Market Value Share, by Test Type, 2021
  • Figure 06: Global COVID-19 Diagnostics Market Revenue (US$ Mn), by End-user, 2021
  • Figure 07: Global COVID-19 Diagnostics Market Value Share, by End-user, 2021
  • Figure 08: Global COVID-19 Diagnostics Market Value Share, by Region, 2021
  • Figure 09: Global COVID-19 Diagnostics Market Value (US$ Mn) Forecast, 2020-2031
  • Figure 10: Global COVID-19 Diagnostics Market Value Share Analysis, by Product, 2021 and 2031
  • Figure 11: Global COVID-19 Diagnostics Market Attractiveness Analysis, by Product, 2022-2031
  • Figure 12: Global COVID-19 Diagnostics Market Value Share Analysis, by Test Type, 2021 and 2031
  • Figure 13: Global COVID-19 Diagnostics Market Attractiveness Analysis, by Test Type, 2022-2031
  • Figure 14: Global COVID-19 Diagnostics Market Value Share Analysis, by End-user, 2021 and 2031
  • Figure 15: Global COVID-19 Diagnostics Market Attractiveness Analysis, by End-user, 2022-2031
  • Figure 16: Global COVID-19 Diagnostics Market Value Share Analysis, by Region, 2021 and 2031
  • Figure 17: Global COVID-19 Diagnostics Market Attractiveness Analysis, by Region, 2022-2031
  • Figure 18: North America COVID-19 Diagnostics Market Value (US$ Mn) Forecast and Y-o-Y Growth (%), 2020-2031
  • Figure 19: North America COVID-19 Diagnostics Market Attractiveness Analysis, by Country, 2020-2031
  • Figure 20: North America COVID-19 Diagnostics Market Value Share Analysis, by Country, 2021 and 2031
  • Figure 21: North America COVID-19 Diagnostics Market Value Share Analysis, by Product, 2021 and 2031
  • Figure 22: North America COVID-19 Diagnostics Market Value Share Analysis, by Test Type, 2021 and 2031
  • Figure 23: North America COVID-19 Diagnostics Market Value Share Analysis, by End-user, 2021 and 2031
  • Figure 24: North America COVID-19 Diagnostics Market Attractiveness Analysis, by Product, 2022-2031
  • Figure 25: North America COVID-19 Diagnostics Market Attractiveness Analysis, by Test Type, 2022-2031
  • Figure 26:North America COVID-19 Diagnostics Market Attractiveness Analysis, by End-user, 2022-2031
  • Figure 27: Europe COVID-19 Diagnostics Market Value (US$ Mn) Forecast and Y-o-Y Growth (%), 2020-2031
  • Figure 28: Europe COVID-19 Diagnostics Market Attractiveness Analysis, by Country/Sub-region, 2020-2031
  • Figure 29: Europe COVID-19 Diagnostics Market Value Share Analysis, by Country/Sub-region, 2021 and 2031
  • Figure 30: Europe COVID-19 Diagnostics Market Value Share Analysis, by Product, 2021 and 2031
  • Figure 31: Europe COVID-19 Diagnostics Market Value Share Analysis, by Test Type, 2021 and 2031
  • Figure 32: Europe COVID-19 Diagnostics Market Value Share Analysis, by End-user, 2021 and 2031
  • Figure 33: Europe COVID-19 Diagnostics Market Attractiveness Analysis, by Product, 2022-2031
  • Figure 34: Europe COVID-19 Diagnostics Market Attractiveness Analysis, by Test Type, 2022-2031
  • Figure 35: Europe COVID-19 Diagnostics Market Attractiveness Analysis, by End-user, 2022-2031
  • Figure 36: Asia Pacific COVID-19 Diagnostics Market Value (US$ Mn) Forecast and Y-o-Y Growth (%), 2020-2031
  • Figure 37: Asia Pacific COVID-19 Diagnostics Market Attractiveness Analysis, by Country/Sub-region, 2020-2031
  • Figure 38: Asia Pacific COVID-19 Diagnostics Market Value Share Analysis, by Country/Sub-region, 2021 and 2031
  • Figure 39: Asia Pacific COVID-19 Diagnostics Market Value Share Analysis, by Product, 2021 and 2031
  • Figure 40: Asia Pacific COVID-19 Diagnostics Market Value Share Analysis, by Test Type, 2021 and 2031
  • Figure 41: Asia Pacific COVID-19 Diagnostics Market Value Share Analysis, by End-user, 2021 and 2031
  • Figure 42: Asia Pacific COVID-19 Diagnostics Market Attractiveness Analysis, by Product, 2022-2031
  • Figure 43: Asia Pacific COVID-19 Diagnostics Market Attractiveness Analysis, by Test Type, 2022-2031
  • Figure 44: Asia Pacific COVID-19 Diagnostics Market Attractiveness Analysis, by End-user, 2022-2031
  • Figure 45: Latin America COVID-19 Diagnostics Market Value (US$ Mn) Forecast and Y-o-Y Growth (%), 2020-2031
  • Figure 46: Latin America COVID-19 Diagnostics Market Attractiveness Analysis, by Country/Sub-region, 2020-2031
  • Figure 47: Latin America COVID-19 Diagnostics Market Value Share Analysis, by Country/Sub-region, 2021 and 2031
  • Figure 48: Latin America COVID-19 Diagnostics Market Value Share Analysis, by Product, 2021 and 2031
  • Figure 49: Latin America COVID-19 Diagnostics Market Value Share Analysis, by Test Type, 2021 and 2031
  • Figure 50: Latin America COVID-19 Diagnostics Market Value Share Analysis, by End-user, 2021 and 2031
  • Figure 51: Latin America COVID-19 Diagnostics Market Attractiveness Analysis, by Product, 2022-2031
  • Figure 52: Latin America COVID-19 Diagnostics Market Attractiveness Analysis, by Test Type, 2022-2031
  • Figure 53: Latin America COVID-19 Diagnostics Market Attractiveness Analysis, by End-user, 2022-2031
  • Figure 54: Middle East & Africa COVID-19 Diagnostics Market Size (US$ Mn) Forecast and Y-o-Y Growth (%), 2020-2031
  • Figure 55: Middle East & Africa COVID-19 Diagnostics Market Attractiveness Analysis, by Country/Sub-region, 2020-2031
  • Figure 56: Middle East & Africa COVID-19 Diagnostics Market Value Share Analysis, by Country/Sub-region, 2021 and 2031
  • Figure 57: Middle East & Africa COVID-19 Diagnostics Market Value Share Analysis, by Product, 2021 and 2031
  • Figure 58: Middle East & Africa COVID-19 Diagnostics Market Value Share Analysis, by Test Type, 2021 and 2031
  • Figure 59: Middle East & Africa COVID-19 Diagnostics Market Value Share Analysis, by End-user, 2021 and 2031
  • Figure 60: Middle East & Africa COVID-19 Diagnostics Market Attractiveness Analysis, by Product, 2022-2031
  • Figure 61: Middle East & Africa COVID-19 Diagnostics Market Attractiveness Analysis, by Test Type, 2022-2031
  • Figure 62: Middle East & Africa COVID-19 Diagnostics Market Attractiveness Analysis, by End-user, 2022-2031